The spatial contrast sensitivity function (CSF) represents a useful summary of functional vision by measuring the amount of contrast needed to detect or discriminate patterns across a range of spatial scales (Campbell & Robson,
1968). The clinical importance of contrast sensitivity (CS) is supported by research showing that many conditions, including amblyopia (Bradley & Freeman,
1981; Hess & Howell,
1977), glaucoma (Hot, Dul, & Swanson,
2008; Ross, Bron, & Clarke,
1984), macular degeneration (Kleiner, Enger, Alexander, & Fine,
1988), diabetic retinopathy (Della Sala, Bertoni, Somazzi, Stubbe, & Wilkins,
1985; Sokol et al.,
1985), and cataracts (Chylack et al.,
1993; Drews-Bankiewicz, Caruso, Datiles, & Kaiser-Kupfer,
1992), show measurable losses in CS, even in cases where acuity may be in the normal range (Bodis-Wollner,
1972; Jindra & Zemon,
1989; Regan & Neima,
1984; Woods & Wood,
1995). Impairment of CS is also associated with functional disabilities (Rubin & Legge,
1989; Turano, Rubin, & Quigley,
1999), and is often more predictive of performance impairment than are standard acuity measurements (Brabyn, Schneck, Haegerstrom-Portnoy, & Lott,
2001; Ginsburg,
2003; Ginsburg, Evans, Sekule, & Harp,
1982).